SR9009 (STENABOLIC) Pharmaqo

All about product
Specification
Reviews
0
Questions
0
In Stock
Product Code: EU3238
Brand: Pharmaqo
Reviews: 0
139.00€
Specifications: (See all)
Acne
No
Active Half-Life
4-6 hours
Active substance
Stenabolic
Also known as
SR9009, Stenabolic
Aromatization
No
Description

Key Features of SR9009 (STENABOLIC) Pharmaqo and Its Advantages

SR9009 (STENABOLIC) Pharmaqo is at the forefront of a new wave of research chemicals that are generating excitement in the fitness and bodybuilding communities. This compound is often recognized as a metabolic modulator, offering potent effects that can enhance physical performance and metabolic health. One of the key features of SR9009 is its capacity to increase endurance and reduce fat storage by enhancing the body's metabolic functions. This makes it a sought-after tool for athletes and fitness enthusiasts alike.

The mechanism behind SR9009 involves the activation of Rev-ErbA, a protein that plays a crucial role in regulating circadian rhythms, fat storage, and muscle differentiation. This interaction not only boosts endurance levels during intense workouts, but it also promotes fat burning, contributing to improved body composition. With its performance-enhancing capabilities and minimal side effects, SR9009 (STENABOLIC) Pharmaqo stands as an innovative solution in the ever-evolving landscape of performance enhancers, appealing to users looking for an edge in their physical pursuits.

Positive Pharmacological Properties

Understanding the pharmacological profile of SR9009 (STENABOLIC) Pharmaqo is essential for both consumers and professionals in the healthcare field. This compound exhibits several positive pharmacological properties, which include:

  1. Enhanced Endurance: SR9009 has been shown to increase the tolerance for prolonged exertion, making it ideal for athletes.
  2. Fat Loss: The compound encourages the body to utilize fat as a primary energy source, potentially leading to more effective weight management.
  3. Improved Metabolic Rate: Users can experience an elevation in their metabolism, which may assist in maintaining a healthy weight.
  4. Reduction of Inflammatory Responses: SR9009 may help in reducing inflammation levels in the body, contributing to overall health.

While promising, this medication also has specified contraindications. It is not suitable for certain groups, including:

  1. Pregnant women: The effects of the drug during pregnancy are not well studied, and caution is advised.
  2. Children: Safety and efficacy in pediatric populations have not been established.
  3. Individuals with specific medical conditions: Those with liver issues, metabolic disorders, or other underlying health problems should avoid this compound.
  4. Individuals taking certain medications: Interactions with other pharmaceuticals may pose risks, requiring oversight by a healthcare provider.

Active Substance of SR9009 (STENABOLIC) Pharmaqo

The active substance within SR9009 (STENABOLIC) Pharmaqo is a synthetic compound designed to maximize metabolic function and enhance physical performance. Modern trends in the development of such compounds focus on achieving effective outcomes with minimal side effects, as researchers continuously explore the intricacies of metabolic modulation. The evolution of SR9009 exemplifies this focus, as it utilizes cutting-edge findings in biochemistry and molecular biology to pave the way for advanced fitness supplements.

This compound has garnered attention for its unique approach; rather than simply acting as a stimulant, SR9009 modulates specific biological pathways that influence energy expenditure and endurance. Technological advancements in synthesis and delivery systems ensure that users can access this compound's benefits more safely and efficiently. Continued research and innovation will likely enhance the understanding and applications of SR9009, paving the way for a new generation of performance enhancement. As consumer awareness grows, SR9009 (STENABOLIC) Pharmaqo could redefine expectations within the fitness community.

Who is Not Recommended to Use This Medication

While SR9009 (STENABOLIC) Pharmaqo presents opportunities for performance enhancement, certain user groups should abstain from its use. Individuals must be aware of the safety considerations associated with this compound. It is crucial to consult with a healthcare professional before beginning any new supplement regimen, especially for the following groups:

  1. Those with pre-existing health conditions: Individuals with chronic illnesses or metabolic disorders may experience adverse effects.
  2. People taking anticoagulants or other medications: There is a risk of interaction that could pose serious health risks.
  3. Older adults: Age-related changes in metabolism may alter the effects of the drug.
  4. Individuals with allergies: Users should be cautious if they have known allergies to certain compounds or ingredients contained in the supplement.

Prioritizing responsible usage of SR9009 (STENABOLIC) Pharmaqo ensures that individuals can maximize benefits while minimizing potential risks associated with its improper use.

Where to Purchase SR9009 (STENABOLIC) Pharmaqo in the USA

Finding a reliable source for purchasing SR9009 (STENABOLIC) Pharmaqo is an essential aspect of its consumption. As the market has evolved, several reputable suppliers have emerged, offering high-quality products to consumers seeking metabolic enhancement. These products typically occupy a distinctive niche in the realms of dietary supplements and performance enhancers, making it crucial for users to carefully select trustworthy vendors.

Consumers should consider purchasing from established suppliers with positive reviews and transparent practices regarding product sourcing and testing. Additionally, it is advisable to evaluate third-party lab test results to guarantee the purity and potency of the compound. Prioritizing a well-regarded source not only elevates user experience but also reinforces the overall integrity of the supplement market. SR9009 (STENABOLIC) Pharmaqo has significant potential to benefit a wide array of users, assuming they approach purchase and usage with diligence and responsibility.

Specifications
Features
Acne
No
Active Half-Life
4-6 hours
Active substance
Stenabolic
Also known as
SR9009, Stenabolic
Aromatization
No
Blood pressure
No significant impact reported
Chemical name
Ethyl 3-[[(4-chlorobenzyl)((5-nitrothiophen-2-yl)methyl)amino]methyl]pyrrolidine-1-carboxylate
Classification
PPAR alpha modifier
Dosage
20-30 mg/day
Dosage (medical)
Not clinically approved for medical use
Dosage (sports)
Typically 10-40 mg per day
Effects
Increased endurance, reduced fat mass, increased wakefulness
Formula
C20H24ClN3O4S
Half-life
Approximately 4-5 hours
HBR
No
Hepatotoxicity
No
Lab Test
Specific tests for detection in blood or urine not widely detailed
Main action
Activates Rev-ErbA which increases mitochondrial count in muscle, decreases fat storage
Raw Material
STENABOLIC
Side effects
Potential alterations in circadian rhythms, limited data on long-term effects
Storage conditions
Store at room temperature, away from moisture and light
Substance class
Synthetic drug, Rev-ErbA ligand
Trade name
Not available under any trade name as it is not commercially marketed
Use in sports
Used as a performance-enhancing drug, not approved by WADA
Water Retention
No
Manufacturer
Pharmaqo US
Packing
60 tabs (15 mg/ tab)
Reviews
0 / 5
average product rating
0
0
0
0
0

There are no reviews for this product, be the first to leave your review.

Answers & questions

No questions about this product, be the first and ask your question.

SR9009 (STENABOLIC) Pharmaqo
139.00€